Argent Biopharma Limited has released a press release.
Completion of phase ii clinical trial on covid-19 patients
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Argent Biopharma
- September Quarterly Activity and Cashflow Report
- Mgc pharma delivers record consecutive weekly sales growth
- Artemic histology on rats confirm no pathological impact
- First high thc products shipped direct to Brazil patients
- Mgc pharma launches cannepil app
Later from Argent Biopharma
- Further successful results from glioblastoma research
- Mgc pharma completes acquisition of telehealth platform mcc
- Prospectus
- ArtemiC Phase II Clinical Trial Results
- December Quarterly Activity and Cashflow Report
Follow Argent Biopharma into a list and get an email when it puts out news.
Follow Argent Biopharma